EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease

Ahmad Al Samarraie, Maxime Pichette, Guy Rousseau

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24065420 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ahmad Al Samarraie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Faculty of Medicine, University of Montreal, Montréal, QC H3T 1J4, Canada. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Gastrointestinal Microbiome, Atherosclerosis, Hypertension. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerotic cardiovascular disease (ASCVD) is the primary cause of death globally, with nine million deaths directly attributable to ischemic heart diseases in 2020. Since the last few decades, great effort has been put toward primary and secondary prevention strategies through identification and treatment of major cardiovascular risk factors, including hypertension, diabetes, dyslipidemia, smoking, and a sedentary lifestyle. Once labelled “the forgotten organ”, the gut microbiota has recently been rediscovered and has been found to play key functions in the incidence of ASCVD both directly by contributing to the development of atherosclerosis and indirectly by playing a part in the occurrence of fundamental cardiovascular risk factors. Essential gut metabolites, such as trimethylamine N-oxide (TMAO), secondary bile acids, lipopolysaccharides (LPS), and short-chain fatty acids (SCFAs), have been associated with the extent of ischemic heart diseases. This paper reviews the latest data on the impact of the gut microbiome in the incidence of ASCVD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesGastrointestinal MicrobiomeAtherosclerosisHypertensionMyocardial IschemiaHumansMethylamines

Stichwörter der Autor:innen

atherosclerosisatherosclerotic cardiovascular diseasediabetesdyslipidemiagut microbiomegut microbiotahypertensionlipopolysaccharidesrisk factorssecondary bile acidsshort-chain fatty acidstrimethylamine N-oxide

Substanzen

Methylamines

Autor:innen und Institutionen

  • Internal Medicine Department, Faculty of Medicine, University of Montreal, Montréal, QC H3T 1J4, Canada.
  • Cardiology Department, Faculty of Medicine, University of Montreal, Montréal, QC H3T 1J4, Canada.
  • Centre de Biomédecine, CIUSSS-NÎM/Hôpital du Sacré-Cœur, Montréal, QC H4J 1C5, Canada.

Zitieren

APA

Al Samarraie, A., Pichette, M., & Rousseau, G. (2023). Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065420

Vancouver

Al Samarraie A, Pichette M, Rousseau G. Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065420

BibTeX
@article{AlSamarraie2023,
  author = {Al Samarraie, Ahmad and Pichette, Maxime and Rousseau, Guy},
  title = {Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24065420}
}
Kostenlos starten →